GERI-KOT- standardized senna concentrate tablet 
Geri-Care Pharmaceutical Corp

----------

gc 454

Active ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

Warnings

Do not use

for more than 1 week unless directed by a doctor.

Ask a doctor before use if you

Stop use and ask a doctor if you have rectal bleeding or fail to
have a bowel movement after use of a laxative.
These may indicate a serious condition .

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor



Other information

Inactive ingredients

cellulose, croscarmellose sodium,
dicalcium phosphate, hypromellose*, magnesium silicate*,
magnesium stearate, mineral oil*, PEG*, silica*, wax*.
*May contain these ingredients

Package Label

454

GERI-KOT 
standardized senna concentrate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-454
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
MAGNESIUM SILICATE (UNII: 9B9691B2N9)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MINERAL OIL (UNII: T5L8T28FGP)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
CARNAUBA WAX (UNII: R12CBM0EIZ)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize8mm
FlavorImprint Code AZ217
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-454-01100 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2018
2NDC:57896-454-101000 in 1 BOTTLE; Type 0: Not a Combination Product04/01/2018
3NDC:57896-454-20200 in 1 BOTTLE; Type 0: Not a Combination Product08/01/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)04/01/2018
Labeler - Geri-Care Pharmaceutical Corp (611196254)
Registrant - Geri-Care Pharmaceutical Corp (611196254)

Revised: 12/2023
Document Id: 0bdd1f3e-0b05-f050-e063-6394a90a954d
Set id: 7aa66bf1-d765-adce-e053-2991aa0a93a3
Version: 3
Effective Time: 20231206
 
Geri-Care Pharmaceutical Corp